GobyMeds vs Hims & Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
GobyMeds beats Hims & Hers overall, scoring 8.2/10 vs 7.8/10. GobyMeds is more affordable at $119/mo vs $199/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose Hims & Hers for users who want glp-1 access from a well-known, publicly trad.
A side-by-side comparison of GobyMeds and Hims & Hers covering pricing, scores, medication types, insurance, and more to help you decide.
GobyMeds
#13 of 39Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.
Visit GobyMedsHims & Hers
#25 of 39One of the largest and most recognized telehealth platforms in the US, offering compounded GLP-1 medications with a polished user experience and strong brand trust.
Visit Hims & Hers| Feature | GobyMeds | Hims & Hers |
|---|---|---|
| Our Score | 8.2/10 | 7.8/10 |
| Starting Price | $119/mo | $199/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program | Users who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #13 | #25 |
Pros & Cons Compared
GobyMeds
Pros
- +$119/mo starting price is among the most affordable for a full-service compounded program
- +Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
- +Modern patient portal with real-time order tracking and easy provider messaging
- +Quick onboarding — most patients approved and shipped within 48 hours of enrollment
Cons
- −Compounded semaglutide only — no tirzepatide, no brand-name, no oral options
- −Newer company with less track record than established players like Ro or Hims
- −No insurance billing and no superbills for FSA/HSA reimbursement
Hims & Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition means extensive customer support infrastructure and resources
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through their platform
- −Generic support experience — large patient volume means you're less likely to get personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
GobyMeds edges out Hims & Hers with a score of 8.2/10 vs 7.8/10. If budget is your priority, GobyMeds starts at $119/mo compared to Hims & Hers's $199/mo. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose Hims & Hers if you want: users who want glp-1 access from a well-known, publicly traded telehealth brand.